Akebia Therapeutics to Participate in the Piper Sandler 34th Annual Healthcare Conference

CAMBRIDGE, Mass., Nov. 22, 2022 /PRNewswire/ — Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose to better the lives of people impacted by kidney disease, today announced that the company will participate in the Piper Sandler 34th Annual Healthcare…

Click here to view original post